Recognition of Idiopathic Inflammatory Myopathies Underlying Interstitial Lung Diseases.
作者信息
Morina Giulia, Sambataro Domenico, Libra Alessandro, Palmucci Stefano, Colaci Michele, La Rocca Gaetano, Ferro Francesco, Carli Linda, Baldini Chiara, Liuzzo Santa Valentina, Vancheri Carlo, Sambataro Gianluca
机构信息
Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Diseases, Policlinico "G.Rodolico-San Marco", University of Catania, 95123 Catania, Italy.
Artroreuma S.R.L., Outpatient Clinic Associated with the Regional Health System, Mascalucia, 95030 Catania, Italy.
出版信息
Diagnostics (Basel). 2025 Jan 24;15(3):275. doi: 10.3390/diagnostics15030275.
Interstitial Lung Disease (ILD) is one of the most common causes of mortality in idiopathic Inflammatory Myopathies (IIM). Despite these conditions being commonly associated with proximal weakness, skin rashes and arthritis, ILD can be the first or the sole clinical feature in up to 60% of patients, potentially leading to incorrect diagnosis. The early recognition of an underlying IIM in ILD patients can allow for prompt treatment, which could potentially stabilize or even improve the lung disease, also avoiding the development of other clinical features associated with the condition. The objective of this review is to describe the clinical, serological and radiological features associated with IIM-ILD, mainly focusing on dermatomyositis and antisynthetase syndrome.
相似文献
Diagnostics (Basel). 2025-1-24
Ther Adv Musculoskelet Dis. 2021-12-9
Mediterr J Rheumatol. 2019-9-30
Clin Rheumatol. 2017-8-22
Rheumatology (Oxford). 2021-1-5
J Appl Lab Med. 2022-1-5
Clin Rev Allergy Immunol. 2021-2
引用本文的文献
Int J Mol Sci. 2025-7-19
Medicina (Kaunas). 2025-3-26
本文引用的文献
JAMA. 2024-5-21
Nat Rev Rheumatol. 2024-1
Curr Opin Rheumatol. 2023-11-1
Immunotargets Ther. 2023-7-26
Adv Rheumatol. 2023-7-13